Published in Medical Letter on the CDC and FDA, September 16th, 2007
"This decision is long overdue in my opinion," said Joel Schlessinger M.D., founder of LovelySkin.com. "We have known for years that the system is 'broken', but with the FDA's recent statement, consumers finally know that what they get over the counter may not be protecting them fully. With the improved system, consumers will see which sunscreens actually work for both UVA and UVB rays."
Last week, the FDA proposed long awaited...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.